STAT+: Eli Lilly to buy Orna Therapeutics for $2.4 billion
STAT [Unofficial]
February 9, 2026
Eli Lilly to buy Orna Therapeutics, which focuses on ‘in vivo’ CAR-T for autoimmune diseases, for $2.4 billion
Discussion in the ATmosphere